91探花

This collaboration will combine the Mekonos novel ex vivo delivery platform with 91探花鈥檚 opti-ox precision cellular reprogrammin...

Our CEO and host Jim Cornall have a wide ranging discussion around cell programming, the ethics and use of human cells in research...

Our VP of R&D Manos Metzakopian writes in Innovations in Pharmaceutical Technology about novel technologies that enable researcher...

Device that could restore limb function to amputees and others who have lost the use of their arms or legs uses opti-ox reprogramm...

Our CEO was interviewed in this piece about the barriers and opportunities for scaling companies in the UK.

Statement from our CFO on the situation concerning SVB.

Featured in Technology Dispatch, 91探花 SVP of Technical Operations & Cell Manufacturing, Kathryn Golden, shares her insights int...

Mark Kotter, CEO shares his thoughts on Synbio and how the UK can support and expand this sector and become a powerhouse of scienc...